| Derek Surdez, | |
|
105 S Andover Rd, Andover, KS 67002-7920 | |
| (316) 330-2773 | |
| Not Available |
| Full Name | Derek Surdez |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 105 S Andover Rd, Andover, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033604673 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 94-09652 (Kansas) | Primary |
| Entity Name | Medicine Lodge Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407887193 PECOS PAC ID: 6901879410 Enrollment ID: O20040813000561 |
News Archive
IRIN reports on the issue of sexual violence against men as a "weapon of war" in the Democratic Republic of the Congo (DRC), writing, "Sexual violence against men, including rape, is under-reported, poorly addressed and has a severe impact on both men and their families, according to a presentation at the annual Sexual Violence and Research Initiative (SVRI), held in Cape Town, South Africa."
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.
Oncolytics Biotech Inc. today announced that it has received a No Objection Letter from Health Canada to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers.
Researchers at Universitat Aut-noma de Barcelona (UAB) and University of Stockholm have created a computer modelling of the structural malfunctioning of the ApoE4 protein when it enters into contact with the Amyloid beta molecule, the main cause of Alzheimer's disease.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20151112002441 |
News Archive
IRIN reports on the issue of sexual violence against men as a "weapon of war" in the Democratic Republic of the Congo (DRC), writing, "Sexual violence against men, including rape, is under-reported, poorly addressed and has a severe impact on both men and their families, according to a presentation at the annual Sexual Violence and Research Initiative (SVRI), held in Cape Town, South Africa."
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.
Oncolytics Biotech Inc. today announced that it has received a No Objection Letter from Health Canada to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers.
Researchers at Universitat Aut-noma de Barcelona (UAB) and University of Stockholm have created a computer modelling of the structural malfunctioning of the ApoE4 protein when it enters into contact with the Amyloid beta molecule, the main cause of Alzheimer's disease.
› Verified 3 days ago
| Entity Name | Cogent Healthcare Of Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992722953 PECOS PAC ID: 8628076924 Enrollment ID: O20220121000611 |
News Archive
IRIN reports on the issue of sexual violence against men as a "weapon of war" in the Democratic Republic of the Congo (DRC), writing, "Sexual violence against men, including rape, is under-reported, poorly addressed and has a severe impact on both men and their families, according to a presentation at the annual Sexual Violence and Research Initiative (SVRI), held in Cape Town, South Africa."
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.
Oncolytics Biotech Inc. today announced that it has received a No Objection Letter from Health Canada to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers.
Researchers at Universitat Aut-noma de Barcelona (UAB) and University of Stockholm have created a computer modelling of the structural malfunctioning of the ApoE4 protein when it enters into contact with the Amyloid beta molecule, the main cause of Alzheimer's disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derek Surdez, 105 S Andover Rd, Andover, KS 67002-7920 Ph: (316) 330-2773 | Derek Surdez, 105 S Andover Rd, Andover, KS 67002-7920 Ph: (316) 330-2773 |
News Archive
IRIN reports on the issue of sexual violence against men as a "weapon of war" in the Democratic Republic of the Congo (DRC), writing, "Sexual violence against men, including rape, is under-reported, poorly addressed and has a severe impact on both men and their families, according to a presentation at the annual Sexual Violence and Research Initiative (SVRI), held in Cape Town, South Africa."
Cancer researchers at the Stanford University School of Medicine have discovered a promising new chemotherapy target for a deadly form of leukemia. Their discovery hinges on a novel "double agent" role for a molecular signal that regulates cell growth.
Oncolytics Biotech Inc. today announced that it has received a No Objection Letter from Health Canada to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers.
Researchers at Universitat Aut-noma de Barcelona (UAB) and University of Stockholm have created a computer modelling of the structural malfunctioning of the ApoE4 protein when it enters into contact with the Amyloid beta molecule, the main cause of Alzheimer's disease.
› Verified 3 days ago
Matthew G Meschke, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-733-1331 Fax: 316-733-4916 | |
Dr. James Marshall Hartley, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 524 N Andover Rd, Andover, KS 67002 Phone: 316-733-3002 Fax: 316-733-1240 | |
Micah Hall, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 S Andover Rd Ste D, Andover, KS 67002 Phone: 316-733-5120 Fax: 316-733-1280 | |
Michael Wilson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 612 N Andover Rd, Andover, KS 67002 Phone: 316-733-6618 Fax: 316-733-5299 | |
Candi S Nigh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 524 N Andover Rd, Andover, KS 67002 Phone: 316-733-0716 Fax: 316-733-6997 | |
Stephen F Lemons, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-733-1331 Fax: 316-733-4916 |